We are live on ! Find out more
MIM

Monashee Investment Management Portfolio holdings

AUM $184M
1-Year Est. Return 197.43%
This Fund
S&P 500
This Quarter Est. Return
-5.98%
1 Year Est. Return
+197.43%
3 Year Est. Return
+447.04%
5 Year Est. Return
+479.31%
10 Year Est. Return
+5,610.42%
AUM
$345M
AUM Growth
-$59.3M
Cap. Flow
-$22.6M
Cap. Flow %
-6.55%
Top 10 Hldgs %
88.57%
Holding
63
New
19
Increased
2
Reduced
15
Closed
26

Top Buys

Rank Stock Value
1
VTI icon
Vanguard Morningstar Total Stock Market ETF
VTI
+$26.9M
2
ANTX icon
AN2 Therapeutics
ANTX
+$6.57M
3
SEDG icon
SolarEdge
SEDG
+$5.49M
4
SWX icon
Southwest Gas
SWX
+$5.25M
5
TVTX icon
Travere Therapeutics
TVTX
+$2.66M

Top Sells

Rank Stock Value
1
ADC icon
Agree Realty
ADC
+$8.92M
2
FHTX icon
Foghorn Therapeutics
FHTX
+$5.49M
3
NTRA icon
Natera
NTRA
+$5.14M
4
SOFI icon
SoFi Technologies
SOFI
+$4.74M
5
UP icon
Wheels Up
UP
+$4.28M

Sector Composition

Rank Sector Weight
1 Healthcare 16.01%
2 Utilities 2.9%
3 Technology 1.92%
4 Materials 1.65%
5 Communication Services 0.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XLO icon
26
Xilio Therapeutics
XLO
$59.2M
$1.15M 0.33%
11,648
-3,656
-24% -$578K
PRDS
27
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
$1.14M 0.33%
158,196
-341,804
-68% -$3.36M
REVB icon
28
Revelation Biosciences
REVB
$4.49M
$932K 0.27%
+4
New +$2.55M
KREF
29
KKR Real Estate Finance Trust
KREF
$490M
$870K 0.25%
+42,220
New +$887K
OMGA
30
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
$771K 0.22%
123,614
-317,562
-72% -$3.24M
THRN
31
DELISTED
Thorne Healthtech, Inc. Common Stock
THRN
$708K 0.21%
111,250
-100,000
-47% -$538K
KNTK icon
32
Kinetik
KNTK
$8.15B
$551K 0.16%
+17,000
New +$555K
TWST icon
33
Twist Bioscience
TWST
$7.76B
$494K 0.14%
+10,000
New +$554K
CDTX
34
DELISTED
Cidara Therapeutics
CDTX
$307K 0.09%
+18,455
New +$313K
MQ icon
35
Marqeta
MQ
$1.64B
$166K 0.05%
+3,750
New +$174K
ATRA icon
36
Atara Biotherapeutics
ATRA
$76.2M
$93K 0.03%
+400
New +$127K
AFTR.WS
37
DELISTED
AfterNext HealthTech Acquisition Corp Warrants
AFTR.WS
$21K 0.01%
50,318
-16,346
-25% -$8.87K
ADC icon
38
Agree Realty
ADC
$9.25B
– –
-125,000
Closed -$8.92M
FHTX icon
39
Foghorn Therapeutics
FHTX
$377M
– –
-240,000
Closed -$5.49M
HAIN icon
40
Hain Celestial
HAIN
$54.7M
– –
-72,507
Closed -$3.09M
HUMA icon
41
Humacyte
HUMA
$197M
– –
-399,910
Closed -$2.9M
IOT icon
42
Samsara
IOT
$23.1B
– –
-30,000
Closed -$843K
LEGN icon
43
Legend Biotech
LEGN
$4.04B
– –
-30,000
Closed -$1.4M
LOCL icon
44
Local Bounti
LOCL
$26M
– –
-30,769
Closed -$2.58M
NTRA icon
45
Natera
NTRA
$46B
– –
-55,000
Closed -$5.14M
NU icon
46
Nu Holdings
NU
$67.2B
– –
-200,000
Closed -$1.88M
OWL icon
47
Blue Owl Capital
OWL
$18.3B
– –
-220,000
Closed -$3.28M
PERI icon
48
Perion Network
PERI
$358M
– –
-20,000
Closed -$481K
SOFI icon
49
SoFi Technologies
SOFI
$23.5B
– –
-300,000
Closed -$4.74M
SRZN icon
50
Surrozen
SRZN
$297M
– –
-23,333
Closed -$2.25M
1
2
3

Similar funds

SWMG
Sard Wealth Management Group Atlanta, Georgia $184M AUM 11.26% 1-Year Est. Return
IFPL
Investments & Financial Planning LLC Lexington, Kentucky $184M AUM 17.7% 1-Year Est. Return
RFG
RFP Financial Group Atlanta, Georgia $184M AUM 16.06% 1-Year Est. Return
NAM
Nutshell Asset Management Sevenoaks, United Kingdom $184M AUM 2.02% 1-Year Est. Return
GCGM
General Catalyst Group Management Cambridge, Massachusetts $184M AUM 50.45% 1-Year Est. Return
PSAMP
P. Schoenfeld Asset Management (PSAM) New York $184M AUM 97.09% 1-Year Est. Return
GCA
GSI Capital Advisors Newport Beach, California $184M AUM 5.17% 1-Year Est. Return
IVGAV
Index Venture Growth Associates V St. Helier, Jersey $184M AUM

Monashee Investment Management's Q1 2022 Portfolio in Review

As of Q1 2022, Monashee Investment Management held 63 positions worth $345M, down 15% from $405M the previous quarter. Its ten largest holdings account for 89% of the portfolio.

Monashee Investment Management withdrew a net $22.6M in Q1 2022, closing 26 positions and reducing 15 holdings. Its most notable exit was Agree Realty, an estimated $8.92M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 24% a quarter earlier, followed by Utilities and Technology.

Against the trend, Monashee Investment Management opened a new position in AN2 Therapeutics worth $6.53M.

  • Monashee Investment Management's largest Q1 2022 buy was AN2 Therapeutics: 433,330 shares worth $6.53M.
  • Monashee Investment Management added most to Vanguard Morningstar Total Stock Market ETF in Q1 2022, an estimated $26.9M increase.
  • Monashee Investment Management's biggest Q1 2022 reduction was Pardes Biosciences, Inc. Common Stock, cutting an estimated $3.36M.
  • Monashee Investment Management fully exited Agree Realty in Q1 2022, selling an estimated $8.92M.
  • Monashee Investment Management's ten largest holdings make up 89% of its $345M portfolio in Q1 2022.
  • Monashee Investment Management opened 19 new positions and closed 26 in Q1 2022.
  • Monashee Investment Management's portfolio value fell 15% quarter-over-quarter to $345M.

Based on Monashee Investment Management's 13F filing for Q1 2022, filed 12 May 2022.